• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Ocular Therapeutix, Inc. - Common Stock (NQ:OCUL)

    8.495 +0.205 (+2.47%)
    Streaming Delayed Price Updated: 1:52 PM EDT, May 27, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,247,164
    Open 8.240
    Bid (Size) 8.490 (400)
    Ask (Size) 8.500 (1,100)
    Prev. Close 8.290
    Today's Range 8.220 - 8.650
    52wk Range 6.230 - 16.44
    Shares Outstanding 157,749,490
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Acuta Capital Sells 56% of Ocular Therapeutix Shares in Q1 ↗
    Ocular Therapeutix delivers FDA-approved eye therapies and devices, supported by a pipeline targeting multiple ocular diseases. 
    Via The Motley Fool
    Topics Regulatory Compliance Stocks
    News headline image
    What This Fund’s $14 Million Ocular Therapeutix Exit Could Signal for Investors ↗
    Ocular Therapeutix delivers ophthalmic therapies with hydrogel technology and a pipeline targeting retinal and glaucoma conditions. 
    Via The Motley Fool
    Topics Regulatory Compliance

    Performance

    YTD
    -28.1%
    -28.1%
    1 Month
    -10.8%
    -10.8%
    3 Month
    -5.1%
    -5.1%
    6 Month
    -30.0%
    -30.0%
    1 Year
    +22.4%
    +22.4%

    More News

    Read More
    News headline image
    Why Ocular Therapeutix (OCUL) Stock Is Nosediving
    Via StockStory
    Ocular Therapeutix Inc (NASDAQ:OCUL) Misses on Revenue and EPS in Q1 2026, Stock Dips ↗
    Via Chartmill
    News headline image
    Ocular Therapeutix (NASDAQ:OCUL) Reports Sales Below Analyst Estimates In Q1 CY2026 Earnings
    Via StockStory
    News headline image
    Ocular Therapeutix (OCUL) To Report Earnings Tomorrow: Here Is What To Expect
    Via StockStory
    News headline image
    1 Healthcare Stock with Exciting Potential and 2 Facing Headwinds
    Via StockStory
    News headline image
    Signal or Noise: What VR Adviser's Spyre Theraputics Buy Means for Fools ↗
    Via The Motley Fool
    News headline image
    What to Make of VR Adviser's Big Ocular Therapeutix Sell-Down ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    1 Cash-Heavy Stock to Research Further and 2 We Brush Off
    Via StockStory
    News headline image
    3 Reasons to Avoid OCUL and 1 Stock to Buy Instead
    Via StockStory
    News headline image
    3 Stocks Under $10 We Think Twice About
    Via StockStory
    News headline image
    Pharmaceuticals Stocks Q4 Highlights: Ocular Therapeutix (NASDAQ:OCUL)
    Via StockStory
    Topics Artificial Intelligence Intellectual Property
    News headline image
    3 Small-Cap Stocks We’re Skeptical Of
    Via StockStory
    News headline image
    3 of Wall Street’s Favorite Stocks We’re Skeptical Of
    Via StockStory
    News headline image
    Ocular Therapeutix (OCUL) Stock Trades Down, Here Is Why
    Via StockStory
    Topics Economy Stocks
    News headline image
    1 Russell 2000 Stock Worth Investigating and 2 We Avoid
    Via StockStory
    News headline image
    1 Volatile Stock for Long-Term Investors and 2 Facing Challenges
    Via StockStory
    Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗
    Via Chartmill
    Tuesday's pre-market session: top gainers and losers ↗
    Via Chartmill
    News headline image
    Nasdaq, S&P 500 Futures Lower As AI Disruption Fears Linger: Why AAPL, ZIM, OCUL, NCLH Are On Traders' Radar Today ↗
    Via Stocktwits
    Topics Artificial Intelligence ETFs Economy
    News headline image
    OCUL Stock Surges Overnight Ahead Of Crucial Wet AMD Data Readout, Sanofi Takeover Buzz Builds ↗
    Via Stocktwits
    Wondering what's happening in today's after-hours session? ↗
    Via Chartmill
    News headline image
    Sanofi Tightens Grip on Ocular Therapeutix with Revised Bid as Pivotal SOL-1 Trial Results Loom
    Via MarketMinute
    News headline image
    Retina’s ‘Sustained’ Moment: Ocular Therapeutix Braces for Game-Changing Phase 3 AXPAXLI Data
    Via MarketMinute

    Frequently Asked Questions

    Is Ocular Therapeutix, Inc. - Common Stock publicly traded?
    Yes, Ocular Therapeutix, Inc. - Common Stock is publicly traded.
    What exchange does Ocular Therapeutix, Inc. - Common Stock trade on?
    Ocular Therapeutix, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Ocular Therapeutix, Inc. - Common Stock?
    The ticker symbol for Ocular Therapeutix, Inc. - Common Stock is OCUL on the Nasdaq Stock Market
    What is the current price of Ocular Therapeutix, Inc. - Common Stock?
    The current price of Ocular Therapeutix, Inc. - Common Stock is 8.495
    When was Ocular Therapeutix, Inc. - Common Stock last traded?
    The last trade of Ocular Therapeutix, Inc. - Common Stock was at 05/27/26 01:52 PM ET
    What is the market capitalization of Ocular Therapeutix, Inc. - Common Stock?
    The market capitalization of Ocular Therapeutix, Inc. - Common Stock is 1.34B
    How many shares of Ocular Therapeutix, Inc. - Common Stock are outstanding?
    Ocular Therapeutix, Inc. - Common Stock has 1B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.